MitoGenetics is a research and development biomedical technology company producing intellectual property and proprietary compounds designed to improve the health of humans, animals and plants. The Primary focus of the technology is on the regulation of a cell, the basic unit of life, and the cell's organelles called the mitochondria through the use of a novel group of natural chemical products. Our research projects may lead to major breakthroughs in therapeutic strategies in human disease disorders that have been functionally linked to cellular mitochondrial dysfunction.